Ally Bridge Group »

Promis Neurosciences shares owned by Ally Bridge Group

Quarter-by-quarter ownership of Promis Neurosciences (PMN) shares owned by Ally Bridge Group from 13F filings

Historical chart of Ally Bridge Group investment in Promis Neurosciences

Tip: Access up to 7 years of quarterly data

All positions including Promis Neurosciences held by Ally Bridge Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Promis Neurosciences by Ally Bridge Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.7M 249k 6.83

More positions owned by Ally Bridge Group

Replimune Group Call Option (REPL)
Edgewise Therapeutics (EWTX)
Abivax Sa Sponsored Ads (ABVX)
Soleno Therapeutics (SLNO)
Compass Pathways Sponsored Ads Call Option (CMPS)
Atai Beckley Nv SHS
Inventiva Sa Ads (IVA)
Minerva Neurosciences Com New (NERV)
Praxis Precision Medicines I Com New (PRAX)
Taysha Gene Therapies Com Shs (TSHA)
Uniqure Nv SHS Call Option (QURE)
Eupraxia Pharmaceuticals (EPRX)
Ovid Therapeutics (OVID)
Solid Biosciences Com New (SLDB)
Aadi Bioscience (WHWK)

View all positions for Ally Bridge Group

Top funds holding Promis Neurosciences

Ally Bridge Group
Sphera Funds Management
UBS Group
Disciplined Equity Management
Advisor Group Holdings
Federation des caisses Desjardins du Quebec
TD Waterhouse Canada
Tower Research Capital

View all funds holding Promis Neurosciences